Neoadjuvant Tyrosine Kinase Inhibitors (TKIs) Efficacy in EGFR Positive Stage III Nonsmall Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
07:30am - 03:35pm EDT - April 6, 2024



Abstract: JNCCN23-0778 https://jnccn.org/view/journal...


Author(s):
Tags: Clinical Oncology

Display Label Action